January 09, 2025

curATime is looking for partners!

curATime is looking for partners!

The curATime cluster is one of 14 pioneering “Clusters4Future” initiatives funded by the German Federal Ministry of Education and Research (BMBF). Its mission is to promote personalized approaches to combat atherothrombosis-related diseases and to establish the Rhine-Main-Palatinate region as an international driver of innovation.

For the planned second implementation phase, the cluster is seeking new partners from science and industry who share its passion for revolutionary research in the field of cardiovascular diseases. It welcomes companies and institutions that can complement its existing expertise in artificial intelligence and mRNA technology and wish to actively contribute to the success of the cluster.

The curATime cluster aims to develop the next generation of medical solutions and revolutionise patient care!
Contact them for more information:

Our latest News

discover more
New paper by BioThrust: ๐—ก๐—ž-๐Ÿต๐Ÿฎ ๐—ฐ๐—ฒ๐—น๐—น ๐—บ๐—ฎ๐—ป๐˜‚๐—ณ๐—ฎ๐—ฐ๐˜๐˜‚๐—ฟ๐—ถ๐—ป๐—ด ๐—ฏ๐—ฒ๐—ป๐—ฐ๐—ต๐—บ๐—ฎ๐—ฟ๐—ธ ๐—ฎ๐˜ ๐Ÿฎ๐—Ÿ ๐˜€๐—ฐ๐—ฎ๐—น๐—ฒ!

New paper by BioThrust: ๐—ก๐—ž-๐Ÿต๐Ÿฎ ๐—ฐ๐—ฒ๐—น๐—น ๐—บ๐—ฎ๐—ป๐˜‚๐—ณ๐—ฎ๐—ฐ๐˜๐˜‚๐—ฟ๐—ถ๐—ป๐—ด ๐—ฏ๐—ฒ๐—ป๐—ฐ๐—ต๐—บ๐—ฎ๐—ฟ๐—ธ ๐—ฎ๐˜ ๐Ÿฎ๐—Ÿ ๐˜€๐—ฐ๐—ฎ๐—น๐—ฒ!

The bioprocess experts from BioThrust Yasemin van Heuvel, Valentin von Werz and the group of Oliver Spadiut at Technische Universitรคt Wien and the team at SimVantage released this publication on NK-92 cell manufacturing. The team collaborated to compare our ComfyCell bioreactor with a conventional pitched-blade stirred-tank bioreactor (2 L scale). While both systems supported comparable […]

Paul Martini Prize for Professor Alwin Krรคmer

Paul Martini Prize for Professor Alwin Krรคmer

On April 20, 2026, Prof. Alwin Krรคmer, MD, of the Heidelberg Medical Faculty at Heidelberg University, who works at the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, received the 2026 Paul Martini Prize. The prize was awarded for groundbreaking improvements in treatment for some patients with metastases from an unknown primary tumor, known […]

3D-Printed Tissue Substitute

3D-Printed Tissue Substitute

A novel developed biomimetic tissue substitute combines precisely tunable mechanical properties with biological functionality and is now ready for applications in medical technology. The material was developed in the ยปPolyKARDยซ project by the Fraunhofer Institute for Applied Polymer Research IAP and the NMI Natural and Medical Sciences Institute. From April 20 to 24, 2026, the […]

GET IN TOUCH

Stay Updated with bioRNโ€™s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp